Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 50451-50500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06393049
Microdialysis and Jugular Bulb Glucose Profiles During Hyperglycaemic Clamping in Patients with Severe Acute Brain Injury
NARecruiting
14 participants
Started: May 8, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT06487429
Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
PHASE2Recruiting
28 participants
Started: May 8, 2024 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT05555394
Body Awareness Therapy and Biomarkers in Fibromyalgia
NARecruiting
110 participants
Started: May 8, 2024 · Completed: Sep 1, 2025
1 condition2 sponsors2 locations
NCT06552052
A Retrospective and Prospective Natural History of Genetic Vasculopathies
N/ARecruiting
50 participants
Started: May 8, 2024 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT06075797
The PediQUEST Response to Pain Of Children With Neurologic Disability Pilot Randomized Controlled Trial
NARecruiting
60 participants
Started: May 8, 2024 · Completed: Jul 31, 2025
3 conditions6 sponsors4 locations
NCT06184308
Improving Outcomes in PICS With Home-Based Program of Rehabilitation and Health Coaching
NARecruiting
220 participants
Started: May 8, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT06452654
Anti-viral Action Against Type 1 Diabetes Autoimmunity
PHASE4Recruiting
2,252 participants
Started: May 8, 2024 · Completed: Oct 31, 2027
1 condition9 sponsors9 locations
NCT06316531
A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
PHASE3Active, not recruiting
274 participants
Started: May 8, 2024 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05849480
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
PHASE1/PHASE2Recruiting
60 participants
Started: May 8, 2024 · Completed: Jun 1, 2042
3 conditions1 sponsor1 location
NCT05795140
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
PHASE3Recruiting
125 participants
Started: May 8, 2024 · Completed: Jan 3, 2033
1 condition1 sponsor6 locations
NCT06978881
Magnetoencephalography in Psychosis Program
N/AEnrolling by invitation
50 participants
Started: May 8, 2024 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT06370104
Treating Suicidality Remotely
NARecruiting
364 participants
Started: May 7, 2024 · Completed: Apr 25, 2028
1 condition2 sponsors1 location
NCT06375876
Single Session Intervention to Promote Hope
NARecruiting
65 participants
Started: May 7, 2024 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT06799273
MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis
N/ARecruiting
1,400 participants
Started: May 7, 2024 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT06451718
First in Human Study to Assess the Safety and the Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus
NARecruiting
12 participants
Started: May 7, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06782334
AMT-116 in Patients with Solid Tumors
PHASE1/PHASE2Recruiting
144 participants
Started: May 7, 2024 · Completed: Dec 30, 2026
1 condition1 sponsor7 locations
NCT06426810
Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx
NARecruiting
40 participants
Started: May 7, 2024 · Completed: Apr 7, 2027
1 condition1 sponsor1 location
NCT06311162
Early Life Intervention in Pediatrics Supported by E-health - SMOKE
NARecruiting
160 participants
Started: May 7, 2024 · Completed: Jul 31, 2028
6 conditions2 sponsors1 location
NCT06446128
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
EARLY_PHASE1Recruiting
20 participants
Started: May 7, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06848738
Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound
NAEnrolling by invitation
362 participants
Started: May 7, 2024 · Completed: Jun 1, 2026
3 conditions2 sponsors3 locations
NCT06215846
A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors
PHASE1Enrolling by invitation
12 participants
Started: May 7, 2024 · Completed: Jan 28, 2026
1 condition1 sponsor1 location
NCT06300320
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
PHASE2Recruiting
52 participants
Started: May 7, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor12 locations
NCT06335953
ALIGN: Aligning Medications With What Matters Most (Demonstration)
NAActive, not recruiting
360 participants
Started: May 7, 2024 · Completed: Nov 1, 2025
3 conditions2 sponsors1 location
NCT06218875
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
N/ARecruiting
2,000 participants
Started: May 7, 2024 · Completed: Sep 30, 2042
1 condition1 sponsor43 locations
NCT06243016
Breaking Sitting with High-intensity Interval Training for Brain Health
NARecruiting
54 participants
Started: May 7, 2024 · Completed: Jul 31, 2025
1 condition3 sponsors1 location
NCT06301841
An Antibiotic Protocol Guided by a Multimodal Approach in AECOPD With Pneumonia in Intensive Care
NARecruiting
64 participants
Started: May 7, 2024 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT06555211
Cardio and Renovascular Effects of Isometric Exercise in the Healthy Human Measured by PET/CT and MRI
NARecruiting
10 participants
Started: May 7, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06390189
Inflammatory Resolution in Cardiometabolic Health and Disease
N/ARecruiting
240 participants
Started: May 7, 2024 · Completed: Sep 1, 2028
3 conditions1 sponsor1 location
NCT06081218
Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users
NARecruiting
60 participants
Started: May 7, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06574841
Effect of Blood Flow Restriction on Pain Perception, Grip Strength and Nerve Conductivity in CTS Patients.
NARecruiting
30 participants
Started: May 7, 2024 · Completed: Jan 27, 2025
1 condition1 sponsor1 location
NCT06047106
Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.
NARecruiting
60 participants
Started: May 7, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06259903
Subcutaneous Administration of MD-18 in Healthy Subjects
PHASE1Active, not recruiting
35 participants
Started: May 7, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06430502
Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours
NARecruiting
200 participants
Started: May 7, 2024 · Completed: Dec 1, 2027
2 conditions1 sponsor1 location
NCT06618456
Hypnosis Induction and Height Experience in VR - Control Group Comparison and Three Sessions
NAActive, not recruiting
101 participants
Started: May 7, 2024 · Completed: Oct 31, 2024
1 condition3 sponsors1 location
NCT06486090
Effectiveness and Process Evaluation of the Injury-preventive Program #Utviklingsklar
NARecruiting
4,256 participants
Started: May 7, 2024 · Completed: Nov 1, 2025
1 condition6 sponsors5 locations
NCT06521255
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE3Recruiting
244 participants
Started: May 7, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor20 locations
NCT04219449
Thrombophilia In Beta Thalassemia
N/ANot yet recruiting
100 participants
Started: May 7, 2024 · Completed: May 31, 2024
1 condition1 sponsor0 locations
NCT06397989
Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention
NAEnrolling by invitation
5,500 participants
Started: May 7, 2024 · Completed: Nov 30, 2026
5 conditions3 sponsors20 locations
NCT06406985
Developing a Weight Management Class as a Recruitment Tool for an Online Weight Loss Program to Rural Illinois Residents
NAActive, not recruiting
20 participants
Started: May 7, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06504433
The Natural History of Mitochondrial Diseases
N/ARecruiting
500 participants
Started: May 7, 2024 · Completed: May 7, 2034
4 conditions1 sponsor1 location
NCT06514456
Italian Validation of the State Urge to be Physically Active- Questionnaire (SUPAQ-I) in Patients With Eating Disorders
N/ARecruiting
210 participants
Started: May 7, 2024 · Completed: Apr 15, 2026
1 condition1 sponsor1 location
NCT06452966
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
NARecruiting
350 participants
Started: May 7, 2024 · Completed: May 30, 2027
5 conditions1 sponsor1 location
NCT06226168
Effects of Normobaric Hypoxia Exercise Program on Bone Turnover Markers and Metabolism in Premenopausal Women
NARecruiting
60 participants
Started: May 7, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT06865235
Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.
NARecruiting
90 participants
Started: May 7, 2024 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT06263673
Anti-Diabetic Medications to Fight PD and LBD
PHASE4Active, not recruiting
18 participants
Started: May 7, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06411821
Ulixertinib in People With Histiocytic Neoplasms
PHASE2Recruiting
38 participants
Started: May 7, 2024 · Completed: May 31, 2027
1 condition2 sponsors8 locations
NCT06410118
The DreamChanger Intervention in Combination With Imagery Rehearsal Therapy for Children's Nightmares
NAActive, not recruiting
120 participants
Started: May 7, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06276621
Family Bridge Program
NAEnrolling by invitation
728 participants
Started: May 7, 2024 · Completed: May 31, 2026
4 conditions2 sponsors2 locations
NCT06290570
A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
N/ARecruiting
300 participants
Started: May 7, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06070961
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
N/ARecruiting
56 participants
Started: May 7, 2024 · Completed: May 31, 2027
1 condition1 sponsor14 locations